Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
NCT Number: NCT03255746
Hypertension is the major risk factor for cardiovascular and cerebrovascular diseases worldwide. The escalating prevalence of inadequate sleep now parallels that of hypertension. Observational and experimental evidence favoring a causal relation between insufficient sleep and hypertension are particularly compelling - sleeping 6 hours or less per night is associated with a 20-32% higher probability of incident hypertension. Since sleep curtailment is largely voluntary, sleep deficiency may be corrected and the detrimental health consequences potentially reversed.
In this study the investigators aim to investigate the effects of 8 weeks of sleep enhancement/extension vs health education in prehypertensive and stage 1 hypertensive subjects who report habitual short sleep (≤6.5 hours/night).
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Rochester, Minnesota, 55905, United States
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
This regimen combines education and behavioral skills to enable prolonging sleep in chronically sleep deprived subjects so as to better meet participant's sleep needs. This intervention emphasizes plain language communication of cognitive behavioral therapy strategies for initiating and maintaining health behavior change, primarily through using brief action plans (time-limited, personally relevant, behavioral goal setting with confidence), and collaborative problem-solving. Coaching will be provided to modify daily routines and adhere to sleep hygiene practices to allow for extended time in bed.
This is a placebo/attention control condition. Participants will receive health education based on NIH information. Number, duration, and frequency of sessions will be identical to those administered to the intervention group.
Time frame: 8 weeks
changes in ambulatory measure of blood pressure
Time frame: 8 weeks
changes in 24-hour heart rate
Time frame: 8 weeks
changes in baroreflex sensitivity
Time frame: 8 weeks
changes in endothelial function
Time frame: 8 weeks
changes in renin
Time frame: 8 weeks
changes in angiotensin peptides
Time frame: 8 weeks
changes in aldosterone
Time frame: 8 weeks
changes in insulin sensitivity
Time frame: 8 weeks
changes in cortisol
Time frame: 8 weeks
changes in body fat
Time frame: 8 weeks
changes in catecholamines
Mayo Clinic
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06284681
Body Weight, Cardiovascular Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT03816462
Body Weight, Cardiomegaly
Baltimore, Maryland, United States
View Trial DetailsNCT06350604
Behavior, Cardiovascular Diseases
Glassboro, New Jersey, United States
View Trial DetailsNCT06491433
Cardiovascular Diseases, Hypertension
Seoul, South Korea
View Trial Details